Dyslipidemia and blood-brain barrier integrity in Alzheimer's disease

Current Gerontology and Geriatrics Research

Volumn 2012, Issue , 2012, Pages

  Bowman, Gene L ^a   Kaye, Jeffrey A ^a,b,c   Quinn, Joseph F ^a,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Oregon Health and Science University Department of Biomedical Engineering   (United States)

^c PORTLAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862278854     PISSN: 16877063     EISSN: 16877071     Source Type: Journal    
DOI: 10.1155/2012/184042     Document Type: Article

References (20)

1. Link H., Tibbling G., Principles of albumin and IgG analyses in neurological disorders. II. Relation of the concentration of the proteins in serum and cerebrospinal fluid Scandinavian Journal of Clinical and Laboratory Investigation 1977 37 5 391 396 (Pubitemid 8387872)
2. Skoog I., Wallin A., Fredman P., Hesse C., Aevarsson O., Karlsson I., Gottfries C. G., Blennow K., A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia Neurology 1998 50 4 966 971 (Pubitemid 28212823)
3. Bowman G. L., Kaye J. A., Moore M., Waichunas D., Carlson N. E., Quinn J. F., Blood-brain barrier impairment in Alzheimer disease: stability and functional significance Neurology 2007 68 21 1809 1814 (Pubitemid 46791393)
4. Bell R. D., Zlokovic B. V., Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease Acta Neuropathologica 2009 118 1 103 113
5. Zlokovic B. V., An Introduction to the Blood-Brain Barrier 1993 Boca Raton, Fla, USA CRC Press
6. Begley D. J., Brightman M. W., Structural and functional aspects of the blood-brain barrier Progress in Drug Research 2003 61 39 78 (Pubitemid 37187402)
7. de la Torre J. C., Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics The Lancet Neurology 2004 3 3 184 190 (Pubitemid 38232669)
8. Lehmann M., Regland B., Blennow K., Gottfries C. G., Vitamin B12-B6-folate treatment improves blood-brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment Dementia and Geriatric Cognitive Disorders 2003 16 3 145 150 (Pubitemid 36737000)
9. Refolo L. M., Pappolla M. A., Malester B., LaFrancois J., Bryant-Thomas T., Wang R., Tint G. S., Sambamurti K., Duff K., Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model Neurobiology of Disease 2000 7 4 321 331
10. Folstein M. F., Folstein S. E., McHugh P. R., Mini-mental state. A practical method for grading the cognitive state of patients for the clinician Journal of Psychiatric Research 1975 12 3 189 198
11. Dooneief G., Marder K., Tang M. X., Stern Y., The clinical dementia rating scale: community-based validation of profound' and terminal' stages Neurology 1996 46 6 1746 1749 (Pubitemid 26185807)
12. Moroney J. T., Bagiella E., Desmond D. W., Hachinski V. C., Mls P. K., Gustafson L., Brun A., Fischer P., Erkinjuntti T., Rosen W., Paik M. C., Tatemichi T. K., Meta-analysis of the Hachinski ischemic score in pathologically verified dementias Neurology 1997 49 4 1096 1105
13. Yesavage J. A., Brink T. L., Rose T. L., Development and validation of a geriatric depression screening scale: a preliminary report Journal of Psychiatric Research 1982 17 1 37 49 (Pubitemid 13123113)
14. Lipid Research Clinics Program, Manual of Laboratory Operations, Lipid and Lipoprotein Analysis 1982 Edited by Resources DoHaH Bethesda, Md, USA National Heart, Lung and Blood Institute
15. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 2002 106 25 3143 3421
16. Grundy S. M., Cleeman J. I., Daniels S. R., Donato K. A., Eckel R. H., Franklin B. A., Gordon D. J., Krauss R. M., Savage P. J., Smith S. C., Spertus J. A., Costa F., Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement Circulation 2005 112 17 2735 2752 (Pubitemid 41532612)
17. Raffaitin C., Gin H., Empana J. P., Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City study Diabetes Care 2009 32 1 169 174
18. Mozaffarian D., Wu J. H., Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events Journal of the American College of Cardiology 2011 58 20 2047 2067
19. Salen G., Berginer V., Shore V., Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid The New England Journal of Medicine 1987 316 20 1233 1238 (Pubitemid 17069352)
20. Lamon-Fava S., Diffenderfer M. R., Barrett P. H., Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 9 1672 1678